ANL

Adlai Nortye Ltd.

• TipRanks·21h ago

  Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

• TipRanks·07/20 09:06

  Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald

• TipRanks·07/17 10:29

  Adlai Nortye Begins Weekly Dosing Arm in Global Phase 1 Trial of RAS Inhibitor AN9025

• PUBT·07/17 10:04

  Adlai Nortye doses first patient in weekly arm of Phase 1 AN9025 pan-RAS inhibitor trial

• TipRanks·07/16 16:45

  Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target Maintained

• TipRanks·07/16 14:10

  Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL)

• TipRanks·07/16 11:10

  Adlai Nortye doses first patient in AN9025 trial

• Benzinga·07/16 11:04

  Adlai Nortye Doses First Patient In The Intermittent Weekly Dosing Arm In Its Ongoing Phase 1 Clinical Trial Of AN9025, A Pan-RAS(ON) Inhibitor

• Reuters·07/16 11:00

  ADLAI NORTYE ANNOUNCES FIRST PATIENT DOSED IN INTERMITTENT WEEKLY DOSING ARM OF GLOBAL PHASE 1 TRIAL OF PAN-RAS(ON) INHIBITOR AN9025

• NASDAQ·07/16 03:41

  Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data

• PUBT·07/15 14:33

  Adlai Nortye director Roger Sawhney files initial beneficial ownership statement

• PUBT·07/13 11:05

  Adlai Nortye adds MD Anderson’s David Hong, MSK’s Piro Lito to scientific advisory board

• NASDAQ·07/07 03:12

  Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

• Benzinga·06/30 12:03

  Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session